The earnings call highlighted successful product innovations and a strategic cost savings initiative. However, significant revenue declines, EPS reductions, and challenges in key markets such as the U.S. and China, coupled with unfavorable tariff and currency conditions, paint a mixed picture. While the company is optimistic about future growth and margin improvements, current market conditions are challenging.
Company Guidance
During Bruker Corporation's Second Quarter 2025 Earnings Call, CEO Frank Laukien provided updated guidance reflecting challenging market conditions. The company reported a 0.4% year-over-year revenue decrease to $797.4 million, with an organic revenue decline of 7%. Bruker's book-to-bill ratio was in the mid 0.9 range. Due to weaker-than-expected bookings, global tariffs, and currency headwinds, the company lowered its fiscal year 2025 guidance, projecting a flat constant exchange rate revenue growth and an organic revenue decline of 2% to 4%. Additionally, a mid-teens percentage decline in non-GAAP EPS is expected. To mitigate these challenges, Bruker announced an expanded cost savings initiative aimed at reducing annual costs by $100 million to $120 million for fiscal year 2026. Despite current headwinds, Bruker remains optimistic for a partial recovery in fiscal year 2026, driven by anticipated improvements in market conditions and significant cost reductions.
Successful Product Launches
Bruker introduced a number of new instruments at ASMS, enhancing their competitive position in proteomics and metabolomics, which have been well-received in the market.
Growth in CALID Group
The CALID Group revenue increased in the low teens percentage, driven by strong growth in microbiology and infection diagnostics, particularly from the MALDI Biotyper and ELITech Molecular Diagnostics business.
Cost Savings Initiative
Bruker announced a cost savings initiative expected to save $100 million to $120 million annually by 2026, contributing to significant margin improvements.
Bruker (BRKR) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BRKR Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 04, 2025
$37.99
$34.72
-8.61%
May 07, 2025
$39.40
$40.71
+3.32%
Feb 13, 2025
$51.53
$51.03
-0.97%
Nov 05, 2024
$59.16
$61.14
+3.35%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bruker Corp (BRKR) report earnings?
Bruker Corp (BRKR) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Bruker Corp (BRKR) earnings time?
Bruker Corp (BRKR) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.